Results for tag: "FDA Form 483"

The FDA Form 483 market is a subset of the pharmaceutical manufacturing industry. It is a regulatory document issued by the U.S. Food and Drug Administration (FDA) to a pharmaceutical manufacturing facility after an inspection. The form is used to document any observed violations of the FDA's Current Good Manufacturing Practice (CGMP) regulations. It is a critical tool for the FDA to ensure that pharmaceutical products are safe and effective. The FDA Form 483 market is composed of pharmaceutical manufacturers, contract manufacturers, and other related companies. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, Johnson & Johnson, AstraZeneca, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more